Hardik Shah
2026.05.22 13:07

๐Ÿ“ข ๐‰๐”๐’๐“ ๐ˆ๐: Eli Lilly Reports Strong Weight-Loss Data for Oral GLP-1 in Older Adults - $Eli Lilly(LLY.US) $Hims & Hers Health(HIMS.US) $Novo Nordisk AS(NVO.US)

๐Ÿ‘‰ ๐Š๐ž๐ฒ ๐‡๐ข๐ ๐ก๐ฅ๐ข๐ ๐ก๐ญ๐ฌ:

โžค Eli Lilly presented new ๐…๐จ๐ฎ๐ง๐๐š๐ฒ๐จ (orforglipron) data at ๐„๐‚๐Ž ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ”.

โžค Oral GLP-1 showed up to ๐Ÿ๐Ÿ‘.๐ŸŽ% weight loss in adults ๐Ÿ”๐Ÿ“+.

โžค Results came from Phase ๐Ÿ‘ ๐€๐“๐“๐€๐ˆ๐-๐Ÿ and ๐€๐“๐“๐€๐ˆ๐-๐Ÿ trials.

โžค Benefits observed in patients both with and without ๐ญ๐ฒ๐ฉ๐ž ๐Ÿ ๐๐ข๐š๐›๐ž๐ญ๐ž๐ฌ.

โžค Foundayo is the only approved ๐จ๐ซ๐š๐ฅ ๐†๐‹๐-๐Ÿ without food or water restrictions.

โžค Most common side effects were ๐ ๐š๐ฌ๐ญ๐ซ๐จ๐ข๐ง๐ญ๐ž๐ฌ๐ญ๐ข๐ง๐š๐ฅ symptoms like nausea and diarrhea.

โžค Safety profile remained generally ๐œ๐จ๐ง๐ฌ๐ข๐ฌ๐ญ๐ž๐ง๐ญ across age groups.

The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.